Ledger.Open graph →
SEC Form D · filed July 14, 2021

Kriya Therapeutics, Inc

Offering
$100.0M
Sold
$100.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
REDWOOD CITY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Saira Ramasastry · Redwood City, CADirectorRyan Letourneau · Quincy, MADirectorIlan Oren · Redwood City, CADirectorFlowtrack Protocol Fund GP LLC · Miami, FLDirectorShankar Ramaswamy · Redwood City, CAExec · DirectorKeith Manchester · Redwood City, CADirectorBrennan P. Berry · Midland, TXDirectorMatt Posard · Menlo Park, CAExecDaniel Chen · Troy, MIExecSteven E. Decillis Ii · New York, NYDirectorRamon Pitter · Miami, FLDirectorBen Somers · Miami, FLDirectorStephen J. Elia · New York, NYDirectorMatthieu Boujonnier · Quincy, MADirectorJohn F. Cozzi · New York, NYExec · DirectorDaniel Chen · Troy, MIExecRoger Jeffs · Redwood City, CADirectorDana Johnson · Redwood City, CAExecStephen Wilhite · Quincy, MADirectorFlowtrack Fund Management Company LLC · Miami, FLDirectorWarren Rickards · Miami, FLDirectorPaul G. Lukeman · Columbus, OHExec · DirectorC.R. Sincock · Redwood City, CADirectorJeff D. Brown · Wheaton, ILDirectorErp 1031 LLC · Midland, TXExecJames Momtazee · Redwood City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗